cCMV: Prevention, Screening, and Treatment
Joel Waddell, DO, Kim Noble Piper, RN
Wednesday, March 27, 2024
12:00 – 1:00 PM
Click here to join the webinar!
Congenital Cytomegalovirus (cCMV) is the most common infectious cause of birth defects in the United States. cCMV can cause serious health problems for newborn babies, such as hearing loss, vision loss, learning disabilities, developmental delays and microcephaly. Pregnant people who have small children at home or work with small children are more likely to get CMV and pass it along to their babies.
By attending this webinar, participants will be able to:
Joel Waddell, DO, is a Pediatric Infectious Diseases Physician at Blank Children’s Hospital in Des Moines. He received his DO from Des Moines University and went on to complete two fellowships in Pediatric Infectious Diseases and Pediatric Clinical Pharmacology at Children’s Mercy Hospital in Kansas City. In addition to his role as an infectious diseases physician, Dr. Waddell is also the Antimicrobial Stewardship Director at Blank Children’s Hospital.
Kimberly Noble Piper, RN, BS, CPH, CPHG, is the state genetics coordinator for Iowa and the Director of the Center for Congenital and Inherited Disorders at the Iowa Department of Public Health. As the Director the Center for Congenital and Inherited Disorders, Kim is responsible for administrative oversight of the state’s public health genomic programs, one of which is the stillbirth surveillance and prevention program. Other CCID programs include newborn screening, maternal prenatal screening, regional genetics and neuromuscular clinics, congenital Cytomegalovirus (cCMV) awareness and prevention, Iowa Registry for Congenital and Inherited Disorders (Iowa’s birth defects and stillbirth registry), and family health history programming.
CME Information:
Des Moines University is the accredited provider and has approved this educational offering for AMA PRA Category 1 Credit™, American Osteopathic Association credit, nursing contact hours, and continuing education contact hours. The speaker(s) will disclose if any pharmaceuticals, medical procedures, and devices discussed are investigational or unapproved by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director. No ineligible company provided financial support for this continuing education activity. If you have questions regarding continuing education credit, please email cme@dmu.edu.
Partners:
Have a login? Login Now
{{vm.loginInfo.errorMessage}}
Create an Account
Forgot your Username or Password?
Register as Guest
Address
Phone
{{slot.Name}}
{{ vm.EventInfo.EventSettings.NoShowPolicy }}